| Current Price | $87.55 | Mkt Cap | $182.6B |
|---|---|---|---|
| Open | $87.16 | P/E Ratio | 22.82 |
| Prev. Close | $80.90 | Div. (Yield) | $2.08 (2.4%) |
| Daily Range | $87.16 - $87.68 | Volume | 1,792,462 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 1,839,117 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $87.55 | Mkt Cap | $182.6B |
|---|---|---|---|
| Open | $87.16 | P/E Ratio | 22.82 |
| Prev. Close | $80.90 | Div. (Yield) | $2.08 (2.4%) |
| Daily Range | $87.16 - $87.68 | Volume | 1,792,462 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 1,839,117 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
TMFacarchidi
(< 20)
Submitted: 8/14/2020 12:06:04 PM :
Start Price:
$85.01
NYSE:NVS Score:
-19.07
It's the most flexible and versatile of the large pharma companies, and its leadership places tremendous value on scientific effectiveness as well as managerial competence.
Recs
jbswen
(< 20)
Submitted: 3/27/2020 2:10:51 PM :
Start Price:
$79.17
NYSE:NVS Score:
-50.12
With this epidemic and once the find a cure they are for sure to take off
Recs
XMFmarkprvulovic
(< 20)
Submitted: 10/17/2019 4:21:14 AM :
Start Price:
$82.06
NYSE:NVS Score:
-35.32
Growing revenues among most major drugs, with its top therapy seeing an impressive 23% increase in quarterly revenue. Updated clinical results for breast cancer drug are also highly impressive.
Find the members with the highest scoring picks in NVS.
wcwhiner (27.62) Score: +187.74
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Bankwatcher1 | 23.19 | 10/7/2008 |
|
NS | $38.28 | +128.69% | +299.63% | +170.94 | 0 Comment | |
| Spelunkin | 25.42 | 11/2/2009 |
|
5Y | $38.67 | +126.39% | +295.17% | +168.77 | 0 Comment | |
| wcwhiner | 27.62 | 4/28/2009 |
|
NS | $27.73 | +215.75% | +383.56% | +167.82 | 0 Comment | |
| PurePwnage | 98.57 | 11/27/2009 |
|
5Y | $41.02 | +113.45% | +279.60% | +166.15 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $39.09 | +123.97% | +287.25% | +163.28 | 0 Comment | |
| 39272x0 | 30.95 | 12/2/2009 |
|
5Y | $42.06 | +108.14% | +269.78% | +161.64 | 0 Comment | |
| kaChingkaChing | 32.20 | 12/2/2009 |
|
3W | $42.06 | +108.14% | +269.78% | +161.64 | 0 Comment | |
| BridgeTech | < 20 | 5/29/2009 |
|
3Y | $29.84 | +193.38% | +354.83% | +161.45 | 0 Comment | |
| DiamondDawg | 88.76 | 11/25/2009 |
|
5Y | $41.69 | +110.01% | +270.14% | +160.14 | 0 Comment | |
| 39272x4 | < 20 | 11/10/2009 |
|
5Y | $39.99 | +118.91% | +276.44% | +157.53 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
